Dark Horse Consulting Group Revenue and Competitors

Location

N/A

Total Funding

Biotech

Industry

Estimated Revenue & Valuation

  • Dark Horse Consulting Group's estimated annual revenue is currently $12.6M per year.(i)
  • Dark Horse Consulting Group's estimated revenue per employee is $155,000

Employee Data

  • Dark Horse Consulting Group has 81 Employees.(i)
  • Dark Horse Consulting Group grew their employee count by 0% last year.

Dark Horse Consulting Group's People

NameTitleEmail/Phone
1
Founder & CEOReveal Email/Phone
2
Chief Financial OfficerReveal Email/Phone
3
Senior Manager AdministrationReveal Email/Phone
4
Manager, Business OperationsReveal Email/Phone
5
Master Principal, Head RegulatoryReveal Email/Phone
6
ConsultantReveal Email/Phone
7
Sr. ConsultantReveal Email/Phone
8
Master Practice Expert / RegulatoryReveal Email/Phone
9
PrincipalReveal Email/Phone
10
Senior ConsultantReveal Email/Phone
Competitor NameRevenueNumber of EmployeesEmployee GrowthTotal FundingValuation
#1
$4.4M57-8%$53MN/A
#2
$21.2M137-26%$110MN/A
#3
$0.9M60%N/AN/A
#4
$2.3M1515%N/AN/A
#5
$1.6M10-17%N/AN/A
#6
$0.7M950%N/AN/A
#7
$11.5M74-12%N/AN/A
#8
$0.4M27510%$236.7MN/A
#9
$4M51-74%$160MN/A
#10
$2.3M1515%N/AN/A
Add Company

What Is Dark Horse Consulting Group?

Currently hiring, ALL LEVELS, ALL LOCATIONS: https://darkhorseconsultinggroup.com/careers/ AT DARK HORSE CONSULTING, we specialize in the development of Cell and Gene Therapy products. Our experts have extensive Cell and Gene Therapy industry experience: collectively well over two centuries worth, in fact. Our knowledge spans process development, device development, manufacturing, quality systems, preclinical development, regulatory, program management, business development, strategy, due diligence, and financing/investor relations. Many of our consultants also bring experience from adjacent, more mature, sectors, including traditional biologics, small molecules, medical devices, gene editing, and management consulting. As a result, we understand the unique challenges faced by Cell and Gene Therapy developers like none other. We apply best practices from across this and other industries to address the needs of our clients, who range from biopharmaceutical executives to venture capital and private equity investors.

keywords:N/A

N/A

Total Funding

81

Number of Employees

$12.6M

Revenue (est)

0%

Employee Growth %

N/A

Valuation

N/A

Accelerator

Company NameRevenueNumber of EmployeesEmployee GrowthTotal Funding
#1
$8.1M8116%N/A
#2
$21.9M813%N/A
#3
$13.9M8456%N/A
#4
$23M854%N/A
#5
$12.5M86-9%N/A